“Nordic Life Science” partnering conference

10-12 September, 2019
Malmö, Norway

ENYO Pharma will attend the Nordic Life Science Partnering conference in Mälmo to present its projects, technologies and partnering opportunities. At the same conference, ENYO will also participate in a panel discussion hosted by Charles River where several companies will share their experiences on fee for service partnering in drug discovery.

Read more »

Published on 06/09/2019

Healthtech Investor Day

24-25 juin 2019
Paris, FRANCE

ENYO Pharma team will be present in Paris from the 24th to the 25th of June to assist to the “Healthtech Investor days” a European business event. This will be the opportunity to meet investors and pharma companies.

Read more »

Published on 19/06/2019

Sponsor Hep B foundation

ENYO Pharma takes part to the research against Hepatitis B with the development of its FXR agonist EYP001 and support the research is this field by becoming one of the sponsor of the Hep B Foundation which is “a national nonprofit organization dedicated to finding a cure and improving the quality of life for those affected by hepatitis B worldwide”

Read more »

Published on 03/06/2019

Moving to Laënnec

ENYO Pharma will move-in to the new Biosera BioParc Building in Laënnec. It will be a great opportunity as we will be neighbours with Edelris, Erytech Pharma and AB Science. Some CEO, Jean-Yves ORTHOLAND (Edelris), Gil BEYEN (Erytech Pharma) and Jacky VONDERSCHER (ENYO Pharma) recently visited the building under construction.

Read more »

Published on 28/05/2019

China Healthcare Investment Conference

26-28 March, 2019
Shanghai

ENYO Pharma has attended the China Healthcare Investment Conference from the 26th to the 28th of March, 2019. It was a great opportunity to initiate several financing and partneurship discussions.

Read more »

Published on 28/05/2019